Trial Profile
Planned Asia-Pacific trial of NBTXR 3 intratumoral implant (activated by radiotherapy) for the treatment of cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2012
Price :
$35
*
At a glance
- Drugs Hafnium oxide (Primary)
- Indications Head and neck cancer; Liver cancer; Oesophageal cancer; Oropharyngeal cancer; Rectal cancer; Solid tumours
- Focus Therapeutic Use
- 29 Nov 2012 New trial record